Chief Medical Officer

  • 12:24

Immunicum announced today that Peter Suenaert, M.D., Ph.D., has accepted the offer to take the role as the Company’s Chief Medical Officer (CMO). In this role, Dr. Suenaert will oversee preclinical and clinical development of the Company’s immunotherapies pipeline of three diversified technology platforms COMBIG, CD70 and Ad5PTDf35-adenovirus vector.

Press release 160722 – New Chief Medical Officer